Abuelgasim, K. A., Alzahrani, M., Alsharhan, Y., Khairi, M., Hommady, M., Gmati, G., . . . Damlaj, M. (2019). Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma. Bone Marrow Transplant.
Citação norma ChicagoAbuelgasim, Khadega A., et al. "Chemoimmunotherapy With Brentuximab Vedotin Combined With Ifosfamide, Gemcitabine, and Vinorelbine Is Highly Active in Relapsed or Refractory Classical Hodgkin Lymphoma." Bone Marrow Transplant 2019.
Citação norma MLAAbuelgasim, Khadega A., et al. "Chemoimmunotherapy With Brentuximab Vedotin Combined With Ifosfamide, Gemcitabine, and Vinorelbine Is Highly Active in Relapsed or Refractory Classical Hodgkin Lymphoma." Bone Marrow Transplant 2019.